News | May 19, 2023
KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Subscribe To Our Newsletter & Stay Updated
